DOI: https://doi.org/10.26641/1997-9665.2020.3.186-191
Некодуючі РНК: біологічні властивості та шляхи використання.
Анотація
Ключові слова
Повний текст:
PDF (English)Посилання
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, authors. Molecular biology of the cell. 3rd ed. New York: Garland Publishing; 1994. 1616 p.
Lodish H, Berk A, Zipursky AL, Matsudaira P, Baltimore D, Darnell J, authors. Molecular cell biology. 4th ed. New York: W. H. Freeman; 2000. 897 p.
Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO reports. 2001; 2(11): 986–91.
Jiayan Wu, Jingfa Xiao, Zhang Zhang, Xumin Wang, Songnian Hu, Jun Yu. Ribogenomics: the Science and Knowledge of RNA. Genomics Proteomics Bioinformatics. 2014; 12: 57-63.
Balashenko NA, Dromashko SE. Long non-coding RNAs and their functions. Proceedings of the National Academy of Sciences of Belarus. Biological series. 2017; 4: 110–19.
Elbashir SM, Harborth J, Lendeckel W. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411(6836):494–8.
Ohshima K., Inoue K., Fujiwara A. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010; 5(10): 132-47.
Andreeva OE, Krasil’nikov MA. [The phenomenon of RNA interference in oncology: advances, problems and perspectives]. Advances in molecular oncology. 2016; 3:8-15. Russian.
Mann DL. MicroRNAs and the failing heart. N. Engl. J. Med. 2007; 356: 2644-45.
Fedorov AV, Kostareva AA, Galagudza M M. [Perspektivy ispol'zovaniya mikroRNK v kachestve biomarkera ishemicheskogo povrezhdeniya miokarda [MicroRNA as biomarkers of myocardial ischemic injury: a perspective.]. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya [Regional Haemodynamics and Microcirculation], 2012; 11(3): 69-75.
Kung JT, Colognori D, Lee JT. Long Noncoding RNAs: Past, Present, and Future. Genetics. 2013; 193(3): 651-69.
Fire A, Xu S, Montgomery MK. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans. Nature. 1998; 391:806–11.
Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J. 2011;6(9):1130–46.
Angelbello AJ, Chen JL, Childs-Disney JL. Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. Chem Rev. 2018 February 28; 118(4): 1599–1663.
Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature, 2005; 435: 834-38.
Xiao J, Yang B, Lin H. Novel approaches for genespecific interference via manipulating actions of microRNAs : examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol. 2007; 212: 285-92.
Ivkin DYu, Lisitskiy DS, Zakharov EA. [MicroRNA as perspective diagnostic and pharmacologic agents]. Astrahanskiy meditsinskiy jurnal. 2015; 2:8-25. Russian.
Stenvang J. Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012; 3: 1-17.
Patrushev MV, Kamenski PA, Mazunin IO. Mutations in mitochondrial DNA and approaches for their correction. Biochemistry (Mosk.). 2014; 79(11): 1151—60.
Kolesnikova OA, Entelis NS, Jacquin-Becker C. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells. Hum. Mol. Genet. 2004; 13(20): 2519-34.
Kolesnikova OA, Entelis NS, Mireau H. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science. 2000;.289(5486): 1931—33.
Karicheva OZ, Kolesnikova OA, Schirtz T. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Nucleic Acids Res. 2011; 39(18): 8173—86.
Lakunina VA, Baleva VS, Levitskii SA. [RNA import into mitochondria and its use in the gene therapy]. Vestnik Moskovskogo universiteta. Seriâ 16, Biologiâ, 2015; 3:32-6. Russian.
Alexis F, Pridgen E, Molnar LK. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5(4):505–15.
Lu D, Benjamin R, Kim M. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther. 1994; 1:245–52.
Glenn, JS, Ellens H, White JM. Delivery of liposome-encapsulated RNA to cells expressing influenza virus hemagglutinin. Methods Enzymol. 1993; 221:327–39.
Malone RW, Felgner PL, Verma IM. Cationic liposomemediated RNA transfection. Proc. Natl. Acad. Sci. USA. 1989; 86:6077–81.
Haque ME, McIntosh TJ, Lentz BR. Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles “Nature’s own” fusogenic lipid bilayer. Biochemistry 2001;40(14):4340–8.
Rider MA, Hurwitz SN, Meckes DG. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci. Rep. 2016; 6:239-78.
Love KT, Mahon KP, Levins CG. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. USA. 2010;107(5):1864–9.
Lee H, Lytton-Jean AK, Chen Y. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 2012; 7(6):389–93.
Semple SC, Akinc A, Chen J. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 2010; 28(2):172–6.
Probst J, Weide B, Scheel B. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol. Life Sci. 2004; 61:2418-24.
Conry RM, LoBuglio AF, Wright M. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 1995; 55:1397-400.
Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 2000; 30:1-7.
Lorenz C, Fotin-Mleczek M, Roth G. Protein expression from exogenous mRNA Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway. RNA Biolog. 2011; 8(4): 627-36.
Boussif O, Lezoualc’h F, Zanta MA. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA. 1995; 92:7297-301.
Lundberg P, El-Andaloussi S, Johansson H. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 2007; 21:2664-71.
Cullis PR, Hope MJ, Tilcock CP. Lipid polymorphism and the roles of lipids in membranes. Chem. Phys. Lipids. 1986; 40:127-44.
Farhood H, Serbina N, Huang L. The role of dioleoylphosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995; 1235:289-95.
Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol Chem. 2003; 278:44826-31.
Duane A. Mitchell, Smita K. Nair. RNA-transfected dendritic cells in cancer immunotherapy. J. Clin. Invest. 2000;106(9):1065-69.
Morphologia